|
|
|
|
Vol. 58, Issue 6, 1441-1450, December 2000
Institut National de la Santé et de la Recherche
Médicale U128-IFR24, Centre National de la Recherche
Scientifique, Montpellier, France (J.-M.P., S.G.-C., P.M., M.-J.V.)
and Service de Chirurgie, Hopital Saint Eloi, Montpellier, France
(J.-M.F.)
The barbiturate phenobarbital induces the transcription of
cytochromes P450 (CYPs) 2B through the constitutive androstane receptor
(CAR; NR1I3). CAR is a member of the nuclear receptor family (NR1)
mostly expressed in the liver, which heterodimerizes with retinoid X
receptor (RXR) and was shown to transactivate both the phenobarbital
responsive element module of the human CYP2B6 gene and the CYP3A4
xenobiotic response element. Because previous studies in rodent
hepatocyte cultures have shown that the phenobarbital-mediated
induction of CYP2B genes is potentiated by glucocorticoids, we examined
the role of activated glucocorticoid receptor in this process. We show
that submicromolar concentrations of dexamethasone enhance
phenobarbital-mediated induction of CYP3A4, CYP2B6, and CYP2C8 mRNA in
cultured human hepatocytes. In parallel, we observed that
glucocorticoid agonists, such as dexamethasone, prednisolone, or
hydrocortisone, specifically increase human car (hCAR) mRNA expression.
Accumulation of hCAR mRNA parallels that of tyrosine
aminotransferase: both mRNAs reach a maximum at a concentration
of 100 nM dexamethasone and are down-regulated by concomitant treatment
with the glucocorticoid antagonist RU486. Moreover, the effect of
dexamethasone on hCAR mRNA accumulation appears to be of
transcriptional origin because the addition of protein synthesis
inhibitor cycloheximide has no effect, and dexamethasone does not
affect the degradation of hCAR mRNA. Furthermore, dexamethasone increases both basal and phenobarbital-mediated nuclear translocation of CAR immunoreactive protein in human hepatocytes. The up-regulation of CAR mRNA and protein in response to dexamethasone explains the
synergistic effect of this glucocorticoid on phenobarbital-mediated induction of CYP2B genes and the controversial role of the
glucocorticoid receptor on phenobarbital-mediated CYP gene inductions.
This article has been cited by other articles:
![]() |
Y. Jia, G. L. Guo, S. Surapureddi, J. Sarkar, C. Qi, D. Guo, J. Xia, P. Kashireddi, S. Yu, Y.-W. Cho, et al. Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity PNAS, August 30, 2005; 102(35): 12531 - 12536. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rencurel, A. Stenhouse, S. A. Hawley, T. Friedberg, D. G. Hardie, C. Sutherland, and C. R. Wolf AMP-activated Protein Kinase Mediates Phenobarbital Induction of CYP2B Gene Expression in Hepatocytes and a Newly Derived Human Hepatoma Cell Line J. Biol. Chem., February 11, 2005; 280(6): 4367 - 4373. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, S. Faucette, R. Moore, T. Sueyoshi, M. Negishi, and E. LeCluyse Human Constitutive Androstane Receptor Mediates Induction of CYP2B6 Gene Expression by Phenytoin J. Biol. Chem., July 9, 2004; 279(28): 29295 - 29301. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Yuan, G. Wei, L. Dey, T. Karrison, L. Nahlik, S. Maleckar, K. Kasza, M. Ang-Lee, and J. Moss Brief Communication: American Ginseng Reduces Warfarin's Effect in Healthy Patients: A Randomized, Controlled Trial Ann Intern Med, July 6, 2004; 141(1): 23 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, S. Faucette, T. Sueyoshi, R. Moore, S. Ferguson, M. Negishi, and E. L. LeCluyse A Novel Distal Enhancer Module Regulated by Pregnane X Receptor/Constitutive Androstane Receptor Is Essential for the Maximal Induction of CYP2B6 Gene Expression J. Biol. Chem., April 11, 2003; 278(16): 14146 - 14152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. H. Chang, S. M. Bandiera, and J. Chen Constitutive Androstane Receptor and Pregnane X Receptor Gene Expression in Human Liver: Interindividual Variability and Correlation with CYP2B6 mRNA Levels Drug Metab. Dispos., January 1, 2003; 31(1): 7 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pascussi, M. Busson-Le Coniat, P. Maurel, and M.-J. Vilarem Transcriptional Analysis of the Orphan Nuclear Receptor Constitutive Androstane Receptor (NR1I3) Gene Promoter: Identification of a Distal Glucocorticoid Response Element Mol. Endocrinol., January 1, 2003; 17(1): 42 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kocarek, M. S. Dahn, H. Cai, S. C. Strom, and N. A. Mercer-Haines Regulation of CYP2B6 and CYP3A Expression by Hydroxymethylglutaryl Coenzyme A Inhibitors in Primary Cultured Human Hepatocytes Drug Metab. Dispos., December 1, 2002; 30(12): 1400 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. THUM and J. BORLAK Testosterone, cytochrome P450, and cardiac hypertrophy FASEB J, October 1, 2002; 16(12): 1537 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. El-Sankary, V. Bombail, G. G. Gibson, and N. Plant Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element Drug Metab. Dispos., September 1, 2002; 30(9): 1029 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Maglich, C. M. Stoltz, B. Goodwin, D. Hawkins-Brown, J. T. Moore, and S. A. Kliewer Nuclear Pregnane X Receptor and Constitutive Androstane Receptor Regulate Overlapping but Distinct Sets of Genes Involved in Xenobiotic Detoxification Mol. Pharmacol., September 1, 2002; 62(3): 638 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Raucy, L. Mueller, K. Duan, S. W. Allen, S. Strom, and J. M. Lasker Expression and Induction of CYP2C P450 Enzymes in Primary Cultures of Human Hepatocytes J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Drocourt, J.-C. Ourlin, J.-M. Pascussi, P. Maurel, and M.-J. Vilarem Expression of CYP3A4, CYP2B6, and CYP2C9 Is Regulated by the Vitamin D Receptor Pathway in Primary Human Hepatocytes J. Biol. Chem., July 5, 2002; 277(28): 25125 - 25132. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lindley, G. Hamilton, J. S. McCune, S. Faucette, S. S. Shord, R. L. Hawke, H. Wang, D. Gilbert, S. Jolley, B. Yan, et al. The Effect of Cyclophosphamide with and without Dexamethasone on Cytochrome P450 3A4 and 2B6 in Human Hepatocytes Drug Metab. Dispos., July 1, 2002; 30(7): 814 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stankova, S. Turcotte, J. Harris, and M. Rola-Pleszczynski Modulation of Leukotriene B4 Receptor-1 Expression by Dexamethasone: Potential Mechanism for Enhanced Neutrophil Survival J. Immunol., April 1, 2002; 168(7): 3570 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gerbal-Chaloin, M. Daujat, J.-M. Pascussi, L. Pichard-Garcia, M.-J. Vilarem, and P. Maurel Transcriptional Regulation of CYP2C9 Gene. ROLE OF GLUCOCORTICOID RECEPTOR AND CONSTITUTIVE ANDROSTANE RECEPTOR J. Biol. Chem., January 4, 2002; 277(1): 209 - 217. [Abstract] [Full Text] |
||||
![]() |
K. Bodin, L. Bretillon, Y. Aden, L. Bertilsson, U. Broome, C. Einarsson, and U. Diczfalusy Antiepileptic Drugs Increase Plasma Levels of 4beta -Hydroxycholesterolin Humans. EVIDENCE FOR INVOLVEMENT OF CYTOCHROME P450 3A4 J. Biol. Chem., October 12, 2001; 276(42): 38685 - 38689. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Drocourt, J.-M. Pascussi, E. Assenat, J.-M. Fabre, P. Maurel, and M.-J. Vilarem Calcium Channel Modulators of the Dihydropyridine Family Are Human Pregnane X Receptor Activators and Inducers of CYP3A, CYP2B, and CYP2C in Human Hepatocytes Drug Metab. Dispos., October 1, 2001; 29(10): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gerbal-Chaloin, J.-M. Pascussi, L. Pichard-Garcia, M. Daujat, F. Waechter, J.-M. Fabre, N. Carrère, and P. Maurel Induction of CYP2C Genes in Human Hepatocytes in Primary Culture Drug Metab. Dispos., March 1, 2001; 29(3): 242 - 251. [Abstract] [Full Text] |
||||